Skip to content
Screener

Omeros OMER Operating Income

Discontinued — last reported Q2 '23

Operating Income at other companies

Immunome logo
ImmunomeIMNM
-$59.33M-32.9%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
-$57.25M+24.5%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
-$39.05M+12.3%
Annexon logo
AnnexonANNX
-$46.05M+19.8%
CytomX Therapeutics logo
CytomX TherapeuticsCTMX
-$23.78M-1,749%
Vor Biopharma logo
Vor BiopharmaVOR
-$35.16M-5.6%

Other financials

Income statement

See full
Revenue$9.9M
Gross profit$29.7M
Net income$56.1M+268%
EPS (diluted)-$0.59-20.4%

Balance sheet

See full
Cash & equivalents$1.9M-55.3%
Total debt$13.5M-30.3%
Total equity-$63.3M+70.3%
Total assets$286.2M+21.7%

Cash flow

See full
Operating cash flow-$14.5M+59.5%
CapEx--100%
Free cash flow-$14.5M+59.6%

Valuation

See full
Market cap$958.97M+245%
P/S10.7×

Profitability

See full
Gross margin98.9%
Operating margin-181.8%
Net margin-136.6%
FCF margin-121.6%

Returns & leverage

See full
Return on equity86.6%
Debt / equity0.3×-1.1×
Current ratio+1.9×

Where this comes from

Reported directly by Omeros in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The source filing: Omeros’s 10-Q, filed August 9, 2023.

Filed
Aug 9, 2023
Fiscal quarter
Q2 FY2023
Calendar quarter
Q2 2023
Accession
0001558370-23-014095
Line itemThree Months Ended / June 30, 2023Three Months Ended / June 30, 2022Six Months Ended / June 30, 2023Six Months Ended / June 30, 2022
Research and development$29,639$23,516$54,249$47,603
Selling, general and administrative11,26013,92222,36324,881
Total costs and expenses40,89937,43876,61272,484
Loss from operations(40,899)(37,438)(76,612)(72,484)
Interest expense(7,932)(4,927)(15,865)(9,868)
Interest and other income4,5376708,5001,163
Net loss from continuing operations(44,294)(41,695)(83,977)(81,189)
Net income from discontinued operations7,00010,84612,98217,329

Item 1. Financial Statements (unaudited)

FAQ

What is Omeros's operating income?
Omeros (OMER) reported operating income of -$40.9M in Q2 2023.
How has Omeros's operating income changed year-over-year?
Omeros's operating income decreased by 9.2% year-over-year, from -$37.44M to -$40.9M.
What does operating income mean?
Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.

Ask your AI about Omeros's operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude